| 【Company Research】SMIC (981 HK) - 3Q26 earnings: Margin beat on price hikes with mild Q4 guidance |
| 【Sector Research】Consumer Staples - Cosmetics E-commerce Tracker: Skincare drove Oct recovery; MGP & Forest Cabin held trend, Proya accelerated |
| 【Company Research】Kelun-Biotech (6990 HK) - TROP2 ADC updates reinforce sac-TMT’s global positioning |
| 【Sector Research】Consumer - Bi-weekly flow monitor: Short builds in late Oct; Southbound buying concentrates on select names |
| 【Company Research】Hesai Group (HSAI US) - SGI ramp-up ahead of plan although ADAS still sees headwinds |
| 【Company Research】PICC P&C (2328 HK) - 2026 Investor Day: Non-auto personal lines the next growth curve in scale and UW profitability |
| 【公司研究】 药明康德 (603259 CH) - 被移除1260H清单,地缘政治风险扰动再降 |
| 【行业研究】医药 - 海外CXO/生命科学上游3Q26业绩剖析:新签订单维持增长,再次普遍上调2026年业绩指引 |
| 【Company Research】WuXi AppTec (603259 CH) - 2026 Investor Day: CRDMO model capturing next-gen growth |
| 【Company Research】BeOne Medicines (ONC US) - Strong 3Q26 results and solid tumor progress drive further upside |